These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36418422)

  • 1. Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment.
    Sato H; Noma K; Ohara T; Kawasaki K; Akai M; Kobayashi T; Nishiwaki N; Narusaka T; Komoto S; Kashima H; Katsura Y; Kato T; Kikuchi S; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
    Sci Rep; 2022 Nov; 12(1):20152. PubMed ID: 36418422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer.
    Katsube R; Noma K; Ohara T; Nishiwaki N; Kobayashi T; Komoto S; Sato H; Kashima H; Kato T; Kikuchi S; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
    Sci Rep; 2021 Jan; 11(1):1693. PubMed ID: 33462372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
    Watanabe S; Noma K; Ohara T; Kashima H; Sato H; Kato T; Urano S; Katsube R; Hashimoto Y; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
    Cancer Biol Ther; 2019; 20(9):1234-1248. PubMed ID: 31185791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody.
    Kobayashi T; Noma K; Nishimura S; Kato T; Nishiwaki N; Ohara T; Kunitomo T; Kawasaki K; Akai M; Komoto S; Kashima H; Kikuchi S; Tazawa H; Shirakawa Y; Choyke PL; Kobayashi H; Fujiwara T
    Mol Cancer Ther; 2024 Jul; 23(7):1031-1042. PubMed ID: 38638034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
    Akai M; Noma K; Kato T; Nishimura S; Matsumoto H; Kawasaki K; Kunitomo T; Kobayashi T; Nishiwaki N; Kashima H; Kikuchi S; Ohara T; Tazawa H; Choyke PL; Kobayashi H; Fujiwara T
    Br J Cancer; 2024 Jun; 130(10):1647-1658. PubMed ID: 38555315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts.
    Kato T; Furusawa A; Okada R; Inagaki F; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2023 Jan; 22(1):75-88. PubMed ID: 36223542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating near-infrared photoimmunotherapy for targeting fibroblast activation protein-α expressing cells in vitro and in vivo.
    Jin J; Barnett JD; Krishnamachary B; Mironchik Y; Luo CK; Kobayashi H; Bhujwalla ZM
    Cancer Sci; 2023 Jan; 114(1):236-246. PubMed ID: 36169301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
    Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
    PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT.
    Nishimura T; Mitsunaga M; Ito K; Kobayashi H; Saruta M
    Gastric Cancer; 2020 Jan; 23(1):82-94. PubMed ID: 31302791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.
    Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H
    Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Suppression by Anti-Fibroblast Activation Protein Near-Infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts.
    Glabman RA; Olkowski CP; Minor HA; Bassel LL; Kedei N; Choyke PL; Sato N
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-Infrared Photoimmunotherapy Using a Protein Mimetic for EGFR-Positive Salivary Gland Cancer.
    Yamaguchi H; Suzuki T; Okada Y; Ono J; Sano H; Banba A; Sakata H; Ishikawa A; Morita T
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
    Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
    Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
    Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
    Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel Therapy Targeting the Cancer Microenvironment Using Near-Infrared Photoimmunotherapy Leading to Tumor Immune Activation].
    Kato T; Noma K; Furusawa A; Kobayashi H; Fujiwara T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1361-1363. PubMed ID: 38303275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer.
    Nakamura Y; Ohler ZW; Householder D; Nagaya T; Sato K; Okuyama S; Ogata F; Daar D; Hoa T; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2017 Feb; 16(2):408-414. PubMed ID: 28151706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
    Siddiqui MR; Railkar R; Sanford T; Crooks DR; Eckhaus MA; Haines D; Choyke PL; Kobayashi H; Agarwal PK
    Sci Rep; 2019 Feb; 9(1):2084. PubMed ID: 30765854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of radiation-induced senescent cancer cells and stromal cells in vitro by near-infrared photoimmunotherapy.
    Suzuki M; Kobayashi H; Hara D; Hanaoka H
    Cancer Med; 2024 Jun; 13(12):e7381. PubMed ID: 38888415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers.
    Cui Y; Xu Y; Li Y; Sun Y; Hu J; Jia J; Li X
    Technol Cancer Res Treat; 2023; 22():15330338221145992. PubMed ID: 36734039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.